Loncar China BioPharma ETF (CHNA)
Assets | $8.34M |
NAV | $20.85 |
Expense Ratio | 0.79% |
PE Ratio | n/a |
Shares Out | 400,000 |
Dividend (ttm) | $3.03 |
Dividend Yield | 14.54% |
Ex-Dividend Date | Dec 29, 2021 |
1-Year Return | -57.32% |
Volume | 2,772 |
Open | 20.11 |
Previous Close | 19.68 |
Day's Range | 20.11 - 20.85 |
52-Week Low | 15.75 |
52-Week High | 49.01 |
Beta | 0.69 |
Holdings | 62 |
Inception Date | Aug 14, 2018 |
About CHNA
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
Top 10 Holdings
27.14% of assetsName | Symbol | Weight |
---|---|---|
Pharmaron Beijing Co Ltd Ordinary Shares - Class H | n/a | 3.16% |
WuXi Biologics (Cayman) Inc | 2269.HK | 3.11% |
Hangzhou Tigermed Consulting Co Ltd Class H | n/a | 3.00% |
Wuxi AppTec Co Ltd | n/a | 2.77% |
Kintor Pharmaceutical Ltd Ordinary Shares | 9939.HK | 2.65% |
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H | n/a | 2.60% |
China Resources Pharmaceutical Group Ltd Registered Shs Unitary 144A/Reg S | 3320.HK | 2.60% |
Legend Biotech | LEGN | 2.50% |
Akeso Inc Ordinary Shares | 9926.HK | 2.41% |
Hansoh Pharmaceutical Group Co Ltd | 3692.HK | 2.33% |
Dividends
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 29, 2021 | $3.0314286 | Dec 31, 2021 |
Dec 30, 2020 | $0.1546187 | Jan 4, 2021 |
Dec 23, 2019 | $0.04024942 | Dec 26, 2019 |
News
Best-Performing ETF Areas of Last Week
Last week was slightly downbeat for Wall Street on talks of a capital gain tax hike with three big U.S. indexes remaining in the red.
4 China ETFs Beating S&P 500 in its Worst Week Since 2008
Check these China ETFs that beat the S&P 500 in the past week, which was U.S. equities?
Best Pharmaceutical ETFs for Q1 2020
The best pharmaceutical ETFs for Q1 2020 are KURE, CHIH, and CHNA.
Why These Chinese Sector ETFs Are Crushing S&P 500 in 2019
Policy easing in the Chinese economy, cooling trade tensions with the United States and Beijing's efforts for more urbanization have boosted these sector ETFs in 2019.